A patient with hemoglobin A1c 8.4% (up from 7.6% three months ago) who is taking Lantus (insulin glargine) 20 units nightly without missed doses—what is the next step in management?

Increase the Lantus Dose Immediately

The next step is to titrate up the Lantus dose using an evidence-based algorithm: increase by 2 units every 3 days until the fasting plasma glucose reaches goal (<100 mg/dL or <5.5 mmol/L), provided there is no hypoglycemia. 1

Rationale for Dose Titration

This patient demonstrates clear inadequate glycemic control with worsening A1c (7.6% → 8.4%) despite adherence to basal insulin. The current dose of 20 units is insufficient, and the 2025 ADA Standards of Care explicitly recommend systematic titration rather than accepting therapeutic inertia 1. The guideline states to "reassess and modify regularly (3-6 months)" and provides a specific titration protocol: increase 2 units every 3 days to reach fasting plasma glucose goal without hypoglycemia 1.

Key Points About Basal Insulin Titration:

• Starting dose considerations: While initial dosing is typically 10 units/day or 0.1-0.2 units/kg/day 1, this patient is already on therapy and requires intensification
• Titration target: Fasting plasma glucose <100 mg/dL (<5.5 mmol/L) 1
• Safety monitoring: If hypoglycemia occurs, determine the cause; if no clear reason exists, lower the dose by 10-20% 1
• Dose adequacy assessment: Should occur at every visit, looking for signs of overbasalization (elevated bedtime-to-morning differential, hypoglycemia, high glucose variability) 1

When Basal Insulin Alone Is Not Enough

If after appropriate titration the A1c remains above goal, the guidelines provide a clear hierarchy 1:

1. First consideration: Add a GLP-1 RA or dual GIP/GLP-1 RA in combination with insulin (may use fixed-ratio products like iGlarLixi or IDegLira if available) 1

   • This approach addresses both fasting and postprandial glucose while minimizing hypoglycemia and weight gain risks
   • GLP-1 RAs can lower A1c by 1-2% when added to metformin 1

2. If A1c remains above goal after adding GLP-1 RA: Consider prandial insulin 1

   • Start with 4 units at the largest meal or meal with greatest postprandial excursion, or 10% of basal insulin dose 1
   • Titrate by 1-2 units or 10-15% based on individualized needs 1

Common Pitfalls to Avoid

• Therapeutic inertia: The most critical error is delaying dose adjustment when A1c is clearly above goal and worsening 1
• Inadequate titration: Many patients remain on suboptimal basal insulin doses; systematic titration algorithms improve outcomes 2
• Premature addition of prandial insulin: Before adding mealtime insulin, ensure basal insulin is optimized AND consider adding GLP-1 RA first to avoid excessive hypoglycemia and weight gain 1, 3
• Overbasalization: Watch for signs that basal insulin alone cannot achieve goals (large bedtime-to-morning glucose differentials, postprandial spikes) 1

Practical Implementation

The patient should:

• Check fasting blood glucose daily during titration
• Increase Lantus by 2 units every 3 days if fasting glucose remains >100 mg/dL
• Hold increases or reduce dose by 10-20% if blood glucose drops <70 mg/dL 1
• Return for reassessment in 3 months, or sooner if hypoglycemia occurs

Research supports that both physician-managed and patient-managed titration algorithms are effective, with patient-managed approaches achieving greater A1c reductions (-1.22% vs -1.08%) though with slightly higher hypoglycemia rates 2. The choice depends on patient capability and preference, but systematic titration is essential regardless of who manages it.